Overexpressing CCT2 in luminal breast cancer cells increased cell proliferation, spheroid growth, and anchorage-independent growth [19], while CCT2 depletion prevented tumor growth in a syngeneic model of triple-negative breast cancer (TNBC) [13]. The gene discussed is CCT2; the disease is breast carcinoma.